GlassScriptPhysician profile
Dean W Moews
NPI 1518917285
$569.89
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $26.18 · 2022: $44.88 · 2023: $212 · 2024: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $160.47 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $97.22 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $63.23 | 2022-2024 | Gardasil 9, Gardasil, Vaxelis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.83 | 2019-2023 | Xifaxan, Trulance |
| E.R. Squibb & Sons, L.L.C. | $39.06 | 2019-2020 | |
| Novo Nordisk INC | $34.06 | 2023-2024 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $28.45 | 2019 | |
| Abbott Laboratories | $23.51 | 2024 | Freestyle Libre 3 |
| Amgen INC. | $20.34 | 2024 | Prolia, Evenity |
| Hologic Sales and Service, LLC | $16.59 | 2024 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $15.98 | 2023 | Paragard T 380a |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.04 | 2020 | |
| Abbvie INC. | $14.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Moews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.